Sihuan Pharmaceutical Holdings Group Ltd. (TEL1.F)
Frankfurt · EUR · Healthcare · Drug Manufacturers - Specialty & Generic
€0.0815 (-0.61%) as of
Key statistics
- Market cap
- 742.95M
- EPS (TTM)
- 0.0000
- Dividend yield
- 2.98%
- 52-week range
- 0.0770 – 0.1810
- Beta
- 0.80
- Revenue (TTM)
- 2.63B
- Profit margin
- 11.46%
- Volume
- 1.00k
About Sihuan Pharmaceutical Holdings Group Ltd.
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China, the United States, and internationally. It operates in three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic devices, body sculpturing, skin care, and other services, as well as non- or minimally invasive comprehensive medical aesthetics solutions. It also provides drugs for cardio-cerebral vascular, digestive system, anti-infective, metabolism, respiratory, neurology, oncology, diabetes, and other indications, as well as modern Chinese medicine and industrial hemp products. In addition, the company offers general hospital services. Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is based in Wan Chai, Hong Kong.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Wan Chai, Hong Kong
- Employees
- 2,712
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.